Sandy Huffaker for The Washington Post via Getty ImagesA 3-year-study of Zepbound and Mounjaro found the GLP-1 drugs can help prevent diabetes.The weekly injections cut the risk of developing diabetes by 94% among adults with high blood sugar.The drugs also prompted significant weight loss: on average, 12-23% of body weight.First, these new injectable drugs were meant to treat diabetes.